Geographic variation in implantable cardioverter-defibrillator use and heart failure survival

Medical Care

Volumn 50, Issue 1, 2012, Pages 10-17

  Epstein, Andrew J ^a,b,c   Polsky, Daniel ^b,c   Yang, Feifei ^b   Yang, Lin ^b   Groeneveld, Peter W ^a,b,c  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

cardiovascular disease; congestive heart failure; health care technology; mortality; utilization

Indexed keywords

AGED; ARTICLE; CARDIAC RESYNCHRONIZATION THERAPY; DEFIBRILLATOR; FEMALE; GEOGRAPHIC DISTRIBUTION; HEALTH CARE UTILIZATION; HEART FAILURE; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICARE; MORTALITY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SURVIVAL RATE; SURVIVAL TIME;

AGED; AGED, 80 AND OVER; CARDIAC RESYNCHRONIZATION THERAPY DEVICES; DEFIBRILLATORS, IMPLANTABLE; FEMALE; HEART FAILURE; HUMANS; MALE; MEDICARE; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; UNITED STATES;

EID: 83455172908     PISSN: 00257079     EISSN: 15371948     Source Type: Journal    
DOI: 10.1097/MLR.0b013e3182293510     Document Type: Article

References (28)

1. Moss AJ, Zareba W, Hall WJ, et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med. 2002;346:877-883. (Pubitemid 34984635)
2. Bardy GH, Lee KL, Mark DB, et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med. 2005;352:225-237. (Pubitemid 40110811)
3. Yarnoz MJ, Curtis AB. Why cardioverter-defibrillator implantation might not be the best idea for your elderly patient. Am J Geriatr Cardiol. 2006;15:367-371.
4. Hernandez AF, Fonarow GC, Hammill BG, et al. Clinical effectiveness of implantable cardioverter-defibrillators among medicare beneficiaries with heart failure. Circ Heart Fail. 2010;3:7-13.
5. Chan PS, Nallamothu BK, Spertus JA, et al. Impact of age and medical comorbidity on the effectiveness of implantable cardioverter-defibrillators for primary prevention. Circ Cardiovasc Qual Outcomes. 2009;2: 16-24.
6. Zipes DP, Camm AJ, Borggrefe M, et al. ACC/AHA/ESC 2006 Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines. Circulation. 2006;114:e385-e484. (Pubitemid 44362500)
7. McClellan MB, Tunis SR. Medicare coverage of ICDs. N Engl J Med. 2005;352:222-224. (Pubitemid 40110810)
8. Assessment of appropriate implantable cardioverter defibrillator (ICD) implantation for primary prevention of sudden cardiac death. Clinicaltrial. gov. Available at: http://clinicaltrials.gov/ct2/show/NCT00926159. Accessed November 3, 2009.
9. Hernandez AF, Fonarow GC, Liang L, et al. Sex and racial differences in the use of implantable cardioverter-defibrillators among patients hospitalized with heart failure. JAMA. 2007;298:1525-1532. (Pubitemid 47529386)
10. Get with the Guidelines-Heart Failure Fact Sheet. American Heart Association. Available at: http://www.americanheart.org/down loadable/heart/1251477226167factsheet-HF-02.pdf. Accessed Nov 10, 2009.
11. Al-Khatib SM, Sanders GD, Carlson M, et al. Preventing tomorrow's sudden cardiac death today: dissemination of effective therapies for sudden cardiac death prevention. Am Heart J. 2008;156:613-622.
12. United States House of Representatives Committee on Ways and Means. Medicare and Health Care Chartbook. Washington: US Government Printing Office; 1999.
13. Health and Human Services Budget in Brief: FY2008. United States Department of Health and Human Services. Available at: http://www.hhs.gov/ budget/08budget/2008BudgetInBrief.pdf. Accessed August 12, 2008.
14. McAlister FA, Ezekowitz J, Hooton N, et al. Cardiac resynchronization therapy for patients with left ventricular systolic dysfunction: a systematic review. JAMA. 2007;297:2502-2514. (Pubitemid 46953404)
15. Redfield MM, Jacobsen SJ, Burnett JC Jr, et al. Burden of systolic and diastolic ventricular dysfunction in the community: appreciating the scope of the heart failure epidemic. JAMA. 2003;289:194-202. (Pubitemid 36068707)
16. Epstein AE, Kay GN, Plumb VJ, et al. Implantable cardioverterdefibrillator prescription in the elderly. Heart Rhythm. 2009;6: 1136-1143.
17. Lash TL, Silliman RA. A comparison of the National Death Index and Social Security Administration databases to ascertain vital status. Epidemiology. 2001;12:259-261. (Pubitemid 32167764)
18. Center for the Evaluative Clinical Sciences-Dartmouth Medical School. The Dartmouth Atlas of Health Care. Available at: www.dart mouthatlas.org. Accessed January 4, 2010.
19. Rosenbaum PR, Rubin DB. Reducing bias in observational studies using subclassification on the propensity score. J Am Stat Assoc. 1984;79: 516-524.
20. Rosenbaum PR, Rubin DB. Constructing a control group using multivariate matched sampling methods that incorporate the propensity score. Am Stat. 1985;39:33-38.
21. Elixhauser A, Steiner C, Harris DR, et al. Comorbidity measures for use with administrative data. Med Care. 1998;36:8-27. (Pubitemid 128456396)
22. Allison PD, eds. Survival Analysis Using SAS: A Practical Guide. Cary, NC: SAS Institute; 1995.
23. Bradfield J, Warner A, Bersohn MM. Low referral rate for prophylactic implantation of cardioverter-defibrillators in a tertiary care medical center. Pacing Clin Electrophysiol. 2009;32(Suppl 1):S194-S197.
24. Wennberg J. Which rate is right? N Engl J Med. 1986;314:310-311. (Pubitemid 16146606)
25. Ammar KA, Jacobsen SJ, Mahoney DW, et al. Prevalence and prognostic significance of heart failure stages: application of the American College of Cardiology/American Heart. Association heart failure staging criteria in the community. Circulation. 2007;115: 1563-1570. (Pubitemid 46648641)
26. Farmer SA, Kirkpatrick JN, Heidenreich PA, et al. Ethnic and racial disparities in cardiac resynchronization therapy. Heart Rhythm. 2009; 6:325-331.
27. Groeneveld PW, Matta MA, Suh JJ, et al. Quality of life among implantable cardioverter-defibrillator recipients in the primary prevention therapeutic era. Pacing Clin Electrophysiol. 2007;30:463-471. (Pubitemid 46596121)
28. Schoenfeld MH. Contemporary pacemaker and defibrillator device therapy: challenges confronting the general cardiologist. Circulation. 2007;115:638-653. (Pubitemid 46226174)